Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.

• Main Authors: Ermias Diro (Author), Tansy Edwards (Author), Koert Ritmeijer (Author), Helina Fikre (Author), Charles Abongomera (Author), Aderajew Kibret (Author), Clélia Bardonneau (Author), Peninah Soipei (Author), Brian Mutinda (Author), Raymond Omollo (Author), Johan van Griensven (Author), Eduard E Zijlstra (Author), Monique Wasunna (Author), Fabiana Alves (Author), Jorge Alvar (Author), Asrat Hailu (Author), Neal Alexander (Author), Séverine Blesson (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2019-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BACKGROUND:The long-term treatment outcome of visceral leishmaniasis (VL) patients with HIV co-infection is complicated by a high rate of relapse, especially when the CD4 count is low. Although use of secondary prophylaxis is recommended, it is not routinely practiced and data on its effectiveness a...